Who we are

The MRCF is a unique collaboration between CSL, major Australian superannuation funds, the Australian and New Zealand governments, Australian state governments and over 50 leading medical research institutes and research hospitals.

The MRCF supports the development and commercialisation of early-stage biomedical discoveries associated with member research organisations, providing both capital and expertise to guide the successful development of new therapies.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    Queensland Government
    Victorian Government
    NSW Government Health
    Ministry of Business, Innovation & Employment NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    Statewide Super
    TelstraSuper
    CSL

Members

Our member institutes span across Australia and New Zealand. Here is a snapshot.

Institute
Telethon Kids Institute

The Telethon Kids Institute is the largest research institute in Western Australia, with a bold vision to improve the health and development of children through excellence in research. Focused on translation, the Institute’s researchers and clinicians work closely, together with our research collaborators across Australia and around the world, to maximise research impact. They have extensive experience in coordinating technology and pharmaceutical interventions – including industry-sponsored trials – across a variety of diseases affecting children

View
Institute
Australian Institute for Bioengineering and Nanotechnology

The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.

View
Institute
Auckland Cancer Society Research Centre

Since its inception in 1956, the Auckland Cancer Society Research Centre (ACSRC) has published nearly 1,000 papers in international scientific and medical journals, and filed more than 100 patent applications for new anti-cancer drugs.

View

Government Partners

Brandon Capital Partners Pty Ltd

Brandon Capital Partners Pty Ltd manages the MRCF Collaboration, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Learn more about the Brandon Capital Team

Investors

The MRCF's investors are AustralianSuper, Statewide Super, HESTA, HOSTPLUS and the Australian Government
under its IIF program.